The Federation of American Societies for Experimental Biology (FASEB) selects the first cohort for its 2024 MOSAIC program, which helps postdoctoral and new investigators transition into independent faculty careers at research-intensive institutions.
FASEB Journals announce the launch of a new article type, Research Letters, designed to offer scientists a fast, focused platform for sharing significant research findings.
Latest research in the FASEB Journal reveals an antibody called bFKB1 improves liver disease and atherosclerosis in a mouse model of metabolic dysfunction-associated steatohepatitis (MASH), which is associated with obesity.
New research in FASEB BioAdvances reveals that a fluorescent dye could help scientists listen to biochemical conversations between cartilage and bone during the earliest stages of osteoarthritis—even before the disease causes pain.
The Federation of American Societies for Experimental Biology (FASEB) announces the 2024 recipients of its CARES Award, which supports researchers in their caregiving role and enables them to focus on their professional development and career advancement.
The Federation of American Societies for Experimental Biology (FASEB) selected nine scientists as the 2024 Howard Garrison Advocacy Fellows.
The Federation of American Societies for Experimental Biology (FASEB) is seeking nominations for its 2025 Excellence in Science Awards, recognizing outstanding women scientists dedicated to advancing the professional development of others, contributing to their scientific society, and impacting the scientific community.
The Federation of American Societies for Experimental Biology (FASEB) and the National Institutes of Health (NIH) invite researchers to submit proposals to the FASEB DataWorks! Prize in recognition for their groundbreaking secondary analysis and data reuse projects that contribute to advancing human health.
In addition to the Journal of Pharmacology and Experimental Therapeutics (JPET), the American Society for Pharmacology and Experimental Therapeutics (ASPET) is including two of its other highly respected journals as part of its Editorial Fellowship program.
The Federation of American Societies for Experimental Biology (FASEB), the largest coalition of biomedical research associations in the United States, received a $2.3 million grant over five years to enhance diversity within the academic biomedical research workforce.
The Federation of American Societies for Experimental Biology (FASEB) invites researchers to submit their most captivating research visuals to the FASEB BioArt Awards competition.
The Federation of American Societies for Experimental Biology (FASEB) appoints the 2024–2025 Early-Career Representatives to the FASEB Board and Science Policy Committee (SPC). As voting members of the FASEB Board and SPC, these newly named ECRs will share unique insights of early-career scientists.
Innovative B cell therapy shows promise in delaying disease onset and reducing inflammation in ALS models, paving the way for Phase I clinical trials.
The Federation of American Societies for Experimental Biology's innovative reverse mentoring program transforms mentorship by empowering early-career researchers to lead the way.
Federation of American Societies for Experimental Biology calls for applications for its Fellows for the Future program.
Announcing Stephen Jameson, Ph.D., as 2024-2025 President of the American Association of Immunologists
Beth A. Garvy, PhD, Professor and Senior Associate Dean for Biomedical Education at University of Kentucky (UK) College of Medicine, was named president of the Federation of American Societies for Experimental Biology (FASEB).
The Federation of American Societies for Experimental Biology (FASEB) launches a new service to stream the latest content from in-person FASEB Science Research Conferences.
The Federation of American Societies for Experimental Biology is now accepting applications for the 2024 Howard Garrison Advocacy Fellowship. This opportunity is open to biological and biomedical researchers in all career stages who wish to engage in collaborative exploration of science advocacy and communications.
New research in The FASEB Journal indicates that expression levels of the RPGRIP1L gene might serve as a new prognostic marker for individuals with invasive breast cancer.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right